ACE Inhibitors - Neonatal Disorders

What are ACE Inhibitors?

ACE (Angiotensin-Converting Enzyme) inhibitors are a class of medication used to treat various cardiovascular conditions by blocking the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor. This leads to dilation of blood vessels, reduced blood pressure, and decreased workload on the heart.

Indications in Pediatrics

ACE inhibitors are primarily used in pediatric patients for managing hypertension, heart failure, and certain types of kidney disease, such as chronic kidney disease (CKD). They can also be used off-label for conditions like diabetic nephropathy and proteinuria.

Commonly Used ACE Inhibitors

Some commonly used ACE inhibitors in pediatrics include:
These medications are selected based on the patient's age, weight, renal function, and specific clinical condition.

Dosage and Administration

Dosage in pediatric patients is highly specific and often calculated based on body weight. For example, Enalapril is typically started at 0.08 mg/kg/day and adjusted based on response and tolerance. It's essential to titrate the dose carefully and monitor for efficacy and side effects.

Side Effects and Monitoring

Common side effects of ACE inhibitors include cough, hyperkalemia, hypotension, and renal impairment. Rare but serious side effects include angioedema and severe renal dysfunction. Monitoring should include regular checks of blood pressure, serum electrolytes, and renal function tests.

Contraindications

ACE inhibitors are contraindicated in patients with a history of angioedema related to previous ACE inhibitor therapy, bilateral renal artery stenosis, or severe renal impairment. They should be used cautiously in patients with a solitary kidney or aortic stenosis.

Drug Interactions

ACE inhibitors can interact with several other medications. For instance, concurrent use with potassium-sparing diuretics or potassium supplements can increase the risk of hyperkalemia. Nonsteroidal anti-inflammatory drugs (NSAIDs) can reduce the efficacy of ACE inhibitors and increase the risk of renal impairment.

Special Considerations

In neonates and infants, the pharmacokinetics of ACE inhibitors can vary significantly. Therefore, careful dose adjustments and close monitoring are essential. In children with renal impairment, dose adjustments are also necessary to avoid toxicity.

Patient and Parent Education

Educating parents about the importance of adherence to medication, monitoring for side effects, and regular follow-up is crucial. Parents should be informed about the signs of serious side effects like angioedema (swelling of the face, lips, or throat) and instructed to seek immediate medical attention if these occur.

Conclusion

ACE inhibitors are valuable medications in the pediatric population for managing hypertension, heart failure, and certain kidney diseases. Proper dosing, monitoring, and patient education are essential to maximize the benefits and minimize the risks associated with these medications.



Relevant Publications

Partnered Content Networks

Relevant Topics